Distinguished Mount Sinai faculty members Dennis S. Charney, MD, Dean of Icahn School of Medicine at Mount Sinai, and Kenneth L. Davis, MD, Chief Executive Officer and President of the Mount Sinai Health System, will make presentations, along with leaders and researchers from Duke University Medical Center, Rensselear Polytechnic Institute, Northwestern University, University of Washington, GlaxoSmithKline, Novartis Venture Funds and Cook Ross, Inc.
“As an institution that places an emphasis on advancing research and best practices simultaneously, we consider Mount Sinai the ideal environment for the leaders of scientific progress to meet, collaborate, and ultimately determine the direction of biomedical and technological advancement. This year’s goal is to emphasize the creative and innovative advantages of team-centric culture,” said Dr. Charney, who is also President for Academic Affairs at the Mount Sinai Health System. “We are proud to continue the institution’s longstanding commitment to maximizing the very best of technology and innovation. Bringing renowned experts from academia, industry, venture capital, journalism and consultancy under one roof is our way of enabling further discoveries that will improve treatments for all patients.”
Scott L. Friedman, MD, Dean for Therapeutic Discovery at the Mount Sinai Health System added, “The rapid pace of discovery in biomedical science necessitates teamwork to achieve success. This year’s SINAInnovations conference will provide a playbook on team science, generating enthusiasm among attendees about implementing team science and creating the synergies that accelerate innovation.”
SINAInnovations is a forum-like atmosphere for investors and innovators from science, medicine, and industry and includes a networking session for trainees, sponsored by Mount Sinai’s Women in Science and Postdoctoral Fellows Association. SINAInnovatio
Copyright©2012 Vocus, Inc.
All rights reserved